search
Back to results

Metabolic and Hemodynamic Reserve in Pediatric SCA

Primary Purpose

Child, Only, Brain Diseases, Sickle Cell Disease

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Carbon Dioxide
Sponsored by
Washington University School of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Child, Only focused on measuring sickle cell anemia, cerebrovascular reactivity, cerebral oxygen metabolism, cortical thickness, gray matter, carbon dioxide, magnetic resonance imaging, brain development

Eligibility Criteria

4 Years - 21 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Healthy Controls:

  • Healthy controls ages 4-21 years of age
  • Able to participate in MRI scan without sedation
  • Not currently pregnant
  • No significant psychiatric history, defined as having a severe psychiatric diagnosis, per PI discretion
  • No history of epilepsy
  • No history of stroke or cerebrovascular disease
  • May have occasional headaches if not taking a daily preventative medication for headaches
  • Not on vasodilatory medication, such as sildenafil or verapamil

Sickle Cell Anemia Participants:

  • Ages 4-21 years of age
  • Hb SS or SBeta-thal
  • Able to participate in MRI scan without sedation
  • Not currently pregnant
  • Not on vasodilatory medication, such as sildenafil or verapamil
  • No known vasculopathy

Sites / Locations

  • Washington University in St. LouisRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Healthy Control

Sickle Cell Anemia

Arm Description

Outcomes

Primary Outcome Measures

Gray Matter cortical thickness
Mean whole brain cortical thickness on high resolution T1 images

Secondary Outcome Measures

Total Brain volume
Total brain volume (gray matter and white matter) on high resolution T1 image
Cerebrovascular Reactivity
Change in blood flow as measured by MRI in response to carbon dioxide

Full Information

First Posted
May 22, 2020
Last Updated
August 24, 2023
Sponsor
Washington University School of Medicine
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
search

1. Study Identification

Unique Protocol Identification Number
NCT04406818
Brief Title
Metabolic and Hemodynamic Reserve in Pediatric SCA
Official Title
The Role of Metabolic and Hemodynamic Reserve in Age-Related Brain Vulnerability in Pediatric Sickle Cell Anemia
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 30, 2021 (Actual)
Primary Completion Date
March 31, 2026 (Anticipated)
Study Completion Date
March 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Washington University School of Medicine
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this research study is to better understand how blood flow and metabolism change can influence brain development in the early decades of life. SCA participants and healthy controls are age and sex-matched for comparison. Within the SCA cohort, children with infarcts may have thinner cortices than those without, reflecting a greater loss. The investigators will examine brain blood flow and metabolism using magnetic resonance imaging (MRI). The brain's blood vessels expand and constrict to regulate blood flow based on the brain's needs. The amount of expanding and contracting the blood vessels may vary by age. The brain's blood flow changes in small ways during everyday activities, such exercise, deep concentration, or normal brain growth. Significant illness or psychological stress may increase the brain's metabolic demand or cause other bigger changes in blood flow. If blood vessels are not able to expand to give more blood flow when metabolic demand is high, the brain may not get all of the oxygen it needs. In extreme circumstances, if the brain is unable to get enough oxygen for a long time, a stroke may occur. Sometimes small strokes occur without other noticeable changes and are only detectable on an MRI. These are sometimes called "silent strokes." In less extreme circumstances, not having a full oxygen supply may cause the brain to grow and develop more slowly than when it has a full supply. One way to test the ability of blood vessels to expand is by measuring blood flow while breathing in carbon dioxide. Carbon dioxide causes blood vessels in the brain to dilate without increasing brain metabolism. During this study participants may be asked to undergo a blood draw, MRI, cognitive assessments, and brief questionnaires. The study team will use a special mask to control the amount of carbon dioxide the participants breathe in.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Child, Only, Brain Diseases, Sickle Cell Disease, Anemia, Sickle Cell
Keywords
sickle cell anemia, cerebrovascular reactivity, cerebral oxygen metabolism, cortical thickness, gray matter, carbon dioxide, magnetic resonance imaging, brain development

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Healthy Control
Arm Type
Active Comparator
Arm Title
Sickle Cell Anemia
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Carbon Dioxide
Intervention Description
Participants inhale carbon dioxide while in magnetic resonance imaging scan to measure cerebrovascular reactivity
Primary Outcome Measure Information:
Title
Gray Matter cortical thickness
Description
Mean whole brain cortical thickness on high resolution T1 images
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Total Brain volume
Description
Total brain volume (gray matter and white matter) on high resolution T1 image
Time Frame
3 years
Title
Cerebrovascular Reactivity
Description
Change in blood flow as measured by MRI in response to carbon dioxide
Time Frame
15 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Healthy Controls: Healthy controls ages 4-21 years of age Able to participate in MRI scan without sedation Not currently pregnant No significant psychiatric history, defined as having a severe psychiatric diagnosis, per PI discretion No history of epilepsy No history of stroke or cerebrovascular disease May have occasional headaches if not taking a daily preventative medication for headaches Not on vasodilatory medication, such as sildenafil or verapamil Sickle Cell Anemia Participants: Ages 4-21 years of age Hb SS or SBeta-thal Able to participate in MRI scan without sedation Not currently pregnant Not on vasodilatory medication, such as sildenafil or verapamil No known vasculopathy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kristin P Guilliams, MD
Phone
3144546120
Email
kristinguilliams@wustl.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kristin P Guilliams, MD
Organizational Affiliation
Washington University School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Washington University in St. Louis
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kristin P Guillliams, MD
Phone
314-454-6120
Email
kristinguilliams@wustl.edu

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The proposed research assets will include MRI scan data and CO2 breathing data from 120 subjects, including pediatric subjects. As children are a vulnerable population, the project team will make the data (with any personally identifiable information redacted) available to qualified investigators under a data sharing agreement that provides for (1) a commitment to using for research purposes only, (2) a commitment to securing the data using appropriate computer technology, and (3) a commitment to destroying the data after analyses are completed. This will be available upon request within 6 months of the grant period ending.
IPD Sharing Time Frame
At study conclusion
IPD Sharing Access Criteria
Upon request by qualified researchers

Learn more about this trial

Metabolic and Hemodynamic Reserve in Pediatric SCA

We'll reach out to this number within 24 hrs